Global Sulphonamides Market Expects Significant 2023 Growth Driven by Increasing Prevalence of Chronic Diseases Worldwide


Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Sulphonamides Market by Form (Capsule, Liquid, Powder), Route of Administration (Oral, Topical), Distribution Channel, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Forecast 2023-2030" report has been added to ResearchAndMarkets.com's offering.

The Global Sulphonamides Market on a global scale is expected to experience substantial growth, with a significant CAGR forecasted for the upcoming period. Regional revenue generation has been boosted by economic and significant infrastructure development.

The analysis of patterns related to domestic production, import and export, and consumption has enabled market participants to capitalize on potential opportunities. Furthermore, the accompanied qualitative and quantitative parameters in the report, including detailed analysis, have highlighted the market's driving and restraining factors.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Sulphonamides Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

  1. Market Penetration: Provides comprehensive information on the market offered by the key players
  2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
  3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
  5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  1. What is the market size and forecast of the Global Sulphonamides Market?
  2. What are the inhibiting factors and impact of COVID-19 shaping the Global Sulphonamides Market during the forecast period?
  3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Sulphonamides Market?
  4. What is the competitive strategic window for opportunities in the Global Sulphonamides Market?
  5. What are the technology trends and regulatory frameworks in the Global Sulphonamides Market?
  6. What is the market share of the leading vendors in the Global Sulphonamides Market?
  7. What modes and strategic moves are considered suitable for entering the Global Sulphonamides Market?



Market Dynamics

Drivers

  • Increasing prevalence of chronic diseases worldwide
  • Substantial availability of affordable sulfonamide drug formulations
  • Awareness regarding sulpha drugs and its therapeutic uses

Restraints

  • Side effects of sulphonamides

Opportunities

  • Increasing research & development in pharmaceutical companies
  • Rapidly advancing medical tourism industry

Challenges

  • Lack of regulatory structure in emerging economies



Companies Mentioned

  • AA Pharma Inc.
  • Abbott Laboratories
  • AbbVie Inc.
  • Bausch Health Companies Inc.
  • Cadila Pharmaceuticals Ltd.
  • Cipla Ltd.
  • F. Hoffmann La Roche Ltd.
  • Fera Science Limited
  • GlaxoSmithKline PLC
  • NorthStar Rx LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Market Segmentation & Coverage:

This research report categorizes the Global Sulphonamides Market in order to forecast the revenues and analyze trends in each of following sub-markets:

  • Based on Form, the market is studied across Capsule, Liquid, Powder, and Tablets. The Capsule is projected to witness significant market share during forecast period.
  • Based on Route of Administration, the market is studied across Oral and Topical. The Topical is projected to witness significant market share during forecast period.
  • Based on Distribution Channel, the market is studied across Online-Store Retailers and Store-Based Retailers. The Store-Based Retailers is projected to witness significant market share during forecast period.
  • Based on Application, the market is studied across Gastrointestinal Tract Infection, Respiratory Tract Infection, Skin Infections, and Urinary Tract Infection. The Respiratory Tract Infection is projected to witness significant market share during forecast period.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

For more information about this report visit https://www.researchandmarkets.com/r/3kfkdq

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Kontaktdaten